Jaap Rip1, Linda Chen2, Robin Hartman3, Angelique van den Heuvel2, Arie Reijerkerk2, Joan van Kregten2, Burt van der Boom2, Chantal C.M. Appeldoorn2, Marco de Boer2, David Maussang2, Elizabeth C. M. de Lange3, Pieter J. Gaillard2
1to-BBB technologies BV , Leiden , The Netherlands and.
2to-BBB technologies BV LeidenThe Netherlands
3Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden University LeidenThe Netherlands